Morphine in the management of dyspnoea in ALS. A pilot study

European Journal of Neurology

Volumn 15, Issue 5, 2008, Pages 445-450

  Clemens, K E ^a   Klaschik, E ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

Amyotrophic lateral sclerosis; Carbon dioxide partial pressure; Dyspnoea; Morphine; Respiratory depression

Indexed keywords

MORPHINE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BREATHING RATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; MALE; OXYGEN SATURATION; OXYGEN THERAPY; PRIORITY JOURNAL; PULSE RATE; RESPIRATION DEPRESSION; TRANSCUTANEOUS CARBON DIOXIDE MONITORING;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALGESIA, PATIENT-CONTROLLED; BLOOD GAS MONITORING, TRANSCUTANEOUS; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NARCOTICS; OXYGEN CONSUMPTION; PILOT PROJECTS; RESPIRATION; RESPIRATORY FUNCTION TESTS;

EID: 41849136505     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02102.x     Document Type: Article

References (34)

1. Borasio GD, Miller RG. Clinical characteristics and management of ALS. Seminars in Neurology 2001 21 : 155 166.
2. Kaplan LM, Hollander D. Respiratory dysfunction in amyotrophic lateral sclerosis. Clinics in Chest Medicine 1994 15 : 675 681.
3. Polkey MI, Lyall RA, Green M, Leigh PN, Moxham J. Expiratory muscle function in amyotrophic lateral sclerosis. American Journal of Respiratory and Critical Care Medicine 1998 158 : 734 741.
4. Stone DJ, Keltz H. The effect of respiratory muscle dysfunction on pulmonary function. American Review of Respiratory Disease 1963 88 : 621 629.
5. Kreitzer SM, Saunders NA, Tyler HR, Ingram RH. Respiratory muscle function in amyotrophic lateral sclerosis. American Review of Respiratory Disease 1978 117 : 437 447.
6. Moosavi SH, Golestanian E, Binks AP, Lansing RW, Brown R, Banzett RB. Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans. Journal of Applied Physiology 2003 94 : 141 154.
7. Oliver D. The quality of care and symptom control - the effects on the terminal phase of ALS/MND. Journal of the Neurological Sciences 1996 139 (Suppl. 134 136.
8. Aboussouan LS, Khan SU, Meeker DP, et al. Effect of non-invasive positive pressure ventilation on survival in amyotrophic lateral sclerosis. Annals of Internal Medicine 1997 127 : 450 453.
9. Bruera E, Macmillan K, MacDonald RN. Effects of morphine on dyspnoea of terminal cancer patients. Journal of Pain and Symptom Management 1999 5 : 341 344.
10. Clemens KE, Klaschik E. Symptomatic therapy of dyspnoea with strong opioids and its effect on ventilation in palliative care patients. Journal of Pain and Symptom Management 2007 33 : 473 481.
11. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory Care 2001 46 : 798 825.
12. Voltz R, Borasio G.D. Palliative therapie in der neurologie. Nervenarzt 1994 65 : 220 225.
13. Praxmarer V, Lahrmann H. Amyotrophic lateral sclerosis - when planning is almost too late. Wiener Medizinische Wochenschrift 2006 156 : 297 301.
14. Schonhofer B, Kohler D. Therapeutic strategies in respiratory insufficiency in amyotrophic lateral sclerosis - possibilities and limits. Nervenarzt 1998 69 : 312 319.
15. Jennings AL, Davies AN, Higgins JPT, Gibbs JSR, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002 57 : 939 944.
16. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001 124 : 2000 2013.
17. McDonald WI, Ron MA. Multiple sclerosis: the disease and its manifestations. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 1999 354 : 1615 1622.
18. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. Neurology 1998 50 : 66 72.
19. Arnulf I, Similowski T, Salachas F, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. American Journal of Respiratory and Critical Care Medicine 2000 161 : 849 856.
20. Similowski T, Attali V, Bensimon G, et al. Diaphracmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. European Respiratory Journal 2000 15 : 332 337.
21. Farrero E, Prats E, Povedano M, Martinez-Matos JA, Manres F, Escararabil J. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest 2005 127 : 2132 2138.
22. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. Journal of the Neurological Sciences 1999 164 : 82 88.
23. de Conno F, Spoldi E, Caraceni A, Ventafridda. Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients? Palliative Medicine 1991 5 : 237 243.
24. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Annals of Internal Medicine 1993 119 : 906 907.
25. Allard P, Lamontagne C, Bernard P, Tremblay C. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management 1999 17 : 256 265.
26. Abernethy AP, Currow DC, Frith P, Fazekas B, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003 327 : 523 528.
27. Sykes NP. Morphine kills the pain, not the patient. Lancet 2007 369 : 1325 1326.
28. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 2002 53 : 2002 2007.
29. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustard in the palliative treatment of cancer. Cancer 1948 1 : 634 656.
30. Borasio GD, Voltz R. Palliative care in amyotrophic lateral sclerosis. Journal of Neurology 1997 244 (Suppl. 4 11 17.
31. Bouillon T, Bruhn J, Roepcke H, Hoeft A. Opioid-induced respiratory depression is associated with increased tidal volume variability. European Journal of Anaesthesiology 2003 20 : 127 133.
32. Barbour SJ, Vandebeek CA, Ansermino JM. Increased tidal volume variability in children is a better marker of opioid-induced respiratory depression than decreased respiratory rate. Journal of Clinical Monitoring and Computing 2004 18 : 171 178.
33. Maydell R, Voltz R. Spezielle neurologische und psychiatrische Erkrankungen. In : Maydell R, Voltz R, eds. Palliativmedizin Neurologie und Psychiatrie. Deutsche Gesellschaft für Palliativmedizin. München, DGP, 1996 : 69 80
34. Nelson LM, McGuire V, Longstreth WT, Matkin C. Population-based case control study of amyotrophic lateral sclerosis in Western Washington State. Cigarette smoking and alcohol consumption. American Journal of Epidemiology 2000 151 : 156 163.